Keith R. Alexandra, CEO - Beauty, has demonstrated a clear selling bias in his recent insider transactions, with no recorded purchases across his holdings in Procter & Gamble (PG) and Thermo Fisher Scientific (TMO). According to SEC Form 4 filings, Alexandra has executed 37 transactions, all of which were either sales or awards, with total sell activity amounting to $3,325,528.29. His most recent sales occurred on October 2, 2025, when he disposed of PG shares worth $60,740.45 and $282,389.80, following an earlier sale on August 21, 2025, where he offloaded shares valued at $121,150.02 and a larger block worth $1,691,826.82.
The majority of Alexandra’s filings relate to stock awards (coded "A"), particularly in TMO, where multiple awards were granted between June 2025 and March 2026, though none carried a reported monetary value. His activity in PG also includes several awards, but the only monetized transactions have been sales. The absence of any buy transactions suggests a consistent pattern of reducing his equity exposure in these holdings, particularly in PG, where his sales have been substantial. The data reflects a focus on liquidating vested positions rather than accumulating additional shares in either company.
AI-assisted summary